| First Physical & Functional Rehab At Wahiawa | |
|
735 California Ave, Wahiawa, HI 96786-1935 | |
| (808) 628-9988 | |
| (808) 621-3388 |
| Full Name | First Physical & Functional Rehab At Wahiawa |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 735 California Ave, Wahiawa, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306919964 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Thomas H Tan |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1114089497 PECOS PAC ID: 4789574005 Enrollment ID: I20070809000156 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Conrad K.r. Cadaoas |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1225123185 PECOS PAC ID: 8325136427 Enrollment ID: I20071126000340 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Jesse Horiuchi |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1467695833 PECOS PAC ID: 3971652744 Enrollment ID: I20090527000542 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Lovely Mona Grace Go |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1730461898 PECOS PAC ID: 2264604552 Enrollment ID: I20111010000476 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Morgan De Lima |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1215203450 PECOS PAC ID: 5597072199 Enrollment ID: I20150915001172 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Joanne Abesamis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1710119748 PECOS PAC ID: 9335469410 Enrollment ID: I20180811000265 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Mary Ann Ramil |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1073150447 PECOS PAC ID: 0547696726 Enrollment ID: I20200206001626 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Rhea Francia O Grims |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720729981 PECOS PAC ID: 9931580032 Enrollment ID: I20220720003926 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Provider Name | Riana Esmena-faria |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1891425997 PECOS PAC ID: 1759762859 Enrollment ID: I20220720003952 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| First Physical & Functional Rehab At Wahiawa 735 California Ave, Wahiawa, HI 96786-1935 Ph: (808) 628-9988 | First Physical & Functional Rehab At Wahiawa 735 California Ave, Wahiawa, HI 96786-1935 Ph: (808) 628-9988 |
News Archive
Researchers in the United States have conducted a study demonstrating that personal assessment of whether respirators and face masks fit properly cannot be relied on in efforts to protect against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Scientists from the U.S. Department of Energy's Lawrence Berkeley National Laboratory have uncovered new clues about the risk of cancer from low-dose radiation, which in this research they define as equivalent to 100 millisieverts or roughly the dose received from ten full-body CT scans.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that ARX-04 (sufentanil sublingual tablet, 30 mcg) met primary and secondary endpoints in a multi-center, double-blind, placebo-controlled Phase 3 trial (SAP301) designed to study the short-term treatment of patients with moderate-to-severe acute pain following ambulatory abdominal surgery.
There is good news for the 27,000 plus people around the world who donate a kidney each year. A study which followed living kidney donors for 10 years found that they were at no greater risk for heart disease than the healthy general population.
"Today's New York Times' article exposes the short-comings of the ‘pharma deal' and how it gives with one hand while taking with the other. Rather than relying on ‘shell games' to lower prescription drug costs, policymakers should return this debate to the need for more competition in the form of real biogenerics reform.
› Verified 5 days ago
Mrs. Reychelle Dacuycuy, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 735 California Ave, Wahiawa, HI 96786 Phone: 808-628-9988 Fax: 808-621-3388 | |
Nicole Marie Napuanani Carter, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 302 California Ave Ste 211, Wahiawa, HI 96786 Phone: 808-622-4942 | |
Patricia Fierro, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 735 California Ave, Wahiawa, HI 96786 Phone: 808-628-9988 | |
Mr. Bernardo Bernardo Soriano, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 916 A Kilani Ave, Wahiawa, HI 96786 Phone: 808-621-6400 | |
Timothy Mark Benedict, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 686 Glennan Road, Schofield Physical Therapy Clinic, Wahiawa, HI 96786 Phone: 808-433-8751 | |
Mrs. Janna Mikie Franczyk, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 302 California Ave, Ste 211, Wahiawa, HI 96786 Phone: 808-622-4942 Fax: 808-622-1335 | |
Wade T Suzuki, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-621-8411 |